GEHC logo GE HealthCare Technologies +
GE HealthCare Technologies
+

GE HealthCare Technologies Overview

Company: GE HealthCare Technologies
CEO: Peter J. Arduini
Symbol: GEHC
Exchange: NASDAQ
Industry: Medical - Healthcare Information Services
Sector: Healthcare
About

GE HealthCare Technologies is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies,luding systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. Theselude contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies maintains its corporate headquarters in Chicago, Illinois.

Continue reading...

GE HealthCare Technologies (GEHC)

  • Stock Price
  • Volume
63.23 +3.23 +5.38%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

GE HealthCare Technologies annual revenue was $20.63 B in 2025.

Net Income

GE HealthCare Technologies annual net income was $2.08 B in 2025.

Employees

GE HealthCare Technologies annual employee count was 0 in 2025.

Revenue by Segment

GE HealthCare Technologies’s revenue by segment: Imaging Segment: $9.25 B, PCS Segment: $3.09 B and PDx Segment: $2.90 B in 2025.

Revenue by Region

GE HealthCare Technologies’s revenue by region: CHINA: $2.03 B, Other Countries: $9.43 B and UNITED STATES: $9.17 B in 2025.

Revenue per Employee

GE HealthCare Technologies revenue per employee was - in 2025.

Profit per Employee

GE HealthCare Technologies profit per employee was - in 2025.

Income Statement

Operating Income

GE HealthCare Technologies annual operating income was $2.76 B in 2025.

Research & Development

GE HealthCare Technologies annual research & development expense was $1.26 B in 2025.

Tax Rate (%)

GE HealthCare Technologies annual Tax Rate was 22.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

GE HealthCare Technologies annual total assets was $36.91 B in 2025.

Total Liabilities

GE HealthCare Technologies annual total liabilities was $26.31 B in 2025.

Capital Expenditure

GE HealthCare Technologies annual capital expenditures was -$482.00 M in 2025.

Ratios

Return on Equity (ROE)

GE HealthCare Technologies annual return on equity(ROE) was 16.19% in 2025.

Return on Assets (ROA)

GE HealthCare Technologies annual return on assets(ROA) was 4.55% in 2025.

Debt to Equity

GE HealthCare Technologies annual debt to equity was 96.38% in 2025.

Profitability

Gross Profit Margin (%)

GE HealthCare Technologies annual gross profit margin was 39.99% in 2025.

Operating Income Margin (%)

GE HealthCare Technologies annual operating income margin was 13.39% in 2025.

Net Income Margin (%)

GE HealthCare Technologies annual net income margin was 10.10% in 2025.

Earning Per Share

GE HealthCare Technologies annual earning per share was $4.56 in 2025.

EBITDA

GE HealthCare Technologies annual EBITDA was $3.79 B in 2025.

Free Cash Flow (FCF)

GE HealthCare Technologies annual free cash flow(FCF) was $1.51 B in 2025.

Valuation

Enterprise value

GE HealthCare Technologies annual enterprise value was $33.44 B in 2025.

Enterprise value to Revenue

GE HealthCare Technologies annual enterprise value to revenue was 1.71 in 2025.

Enterprise value to EBITDA

GE HealthCare Technologies annual enterprise value to EBITDA was 9.34 in 2025.

Competitors’ Revenue

Frequently Asked Questions

Who is the CEO of GE HealthCare Technologies?

Peter J. Arduini is the CEO of GE HealthCare Technologies.

What industry and sector is GE HealthCare Technologies in?

GE HealthCare Technologies operates in the Medical - Healthcare Information Services industry and the Healthcare sector.

What are GE HealthCare Technologies's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0001932393
  • SIC (Standard Industrial Classification):
  • ISIN (International Securities Identification Number): US36266G1076

Sign up for free to view

How many employees does GE HealthCare Technologies have?

GE HealthCare Technologies has 0 employees.

What is the revenue of GE HealthCare Technologies?

In fiscal year 2025, GE HealthCare Technologies generated a revenue of $20.63 Billion.

What is the net income of GE HealthCare Technologies?

In fiscal year 2025, GE HealthCare Technologies reported a net income of $2.08 Billion.

What is GE HealthCare Technologies's biggest product segment?

Imaging Segment is GE HealthCare Technologies's biggest product segment, representing 60.7% of its total revenue.

When was GE HealthCare Technologies listed on the stock exchange?

GE HealthCare Technologies went public on Dec 15, 2022, through its Initial Public Offering (IPO), and it has been 3 years since then.

Sign up for free to view

What is the ticker symbol of GE HealthCare Technologies, and where is it listed?

GE HealthCare Technologies's ticker symbol is GEHC, and the company is listed on the NASDAQ stock market exchange.

What is GE HealthCare Technologies's current stock price?

GE HealthCare Technologies's current stock price is $63.24 as of Jun 17, 2026.

What is GE HealthCare Technologies's market capitalization?

As of , GE HealthCare Technologies's market cap is .

What is GE HealthCare Technologies's ranking in the world?

Ranked #55among 2,804 companies based on market cap.

Who are the top competitors of GE HealthCare Technologies?

Competitors of GE HealthCare Technologies include , and more.

People Also Search For

Submit feedback to Bullfincher